HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by HHM Wealth Advisors LLC

HHM Wealth Advisors LLC cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,953 shares of the company’s stock after selling 540 shares during the quarter. HHM Wealth Advisors LLC’s holdings in HCA Healthcare were worth $1,341,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Stone House Investment Management LLC acquired a new stake in HCA Healthcare in the third quarter valued at $25,000. BluePath Capital Management LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth $27,000. Centerpoint Advisors LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth $27,000. Bruce G. Allen Investments LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth $28,000. Finally, Annis Gardner Whiting Capital Advisors LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth $30,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, SVP Chad J. Wasserman sold 876 shares of the stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the transaction, the senior vice president now directly owns 1,576 shares in the company, valued at approximately $520,474. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In related news, SVP Kathryn A. Torres sold 3,861 shares of the firm’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $307.00, for a total transaction of $1,185,327.00. Following the transaction, the senior vice president now directly owns 15,899 shares in the company, valued at $4,880,993. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Chad J. Wasserman sold 876 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total value of $289,299.00. Following the transaction, the senior vice president now owns 1,576 shares in the company, valued at $520,474. The disclosure for this sale can be found here. In the last three months, insiders sold 14,840 shares of company stock worth $4,588,869. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Trading Down 2.4 %

HCA traded down $7.43 on Friday, reaching $306.69. 2,257,051 shares of the company’s stock were exchanged, compared to its average volume of 1,051,296. The company has a market cap of $81.11 billion, a price-to-earnings ratio of 15.29, a PEG ratio of 1.48 and a beta of 1.65. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $335.83. The company’s 50 day moving average is $323.94 and its 200-day moving average is $295.45. The company has a debt-to-equity ratio of 35.07, a quick ratio of 1.02 and a current ratio of 1.18.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. The firm had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. HCA Healthcare’s quarterly revenue was up 11.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $4.93 EPS. Equities analysts predict that HCA Healthcare, Inc. will post 20.58 earnings per share for the current year.

HCA Healthcare announced that its Board of Directors has authorized a stock buyback program on Tuesday, January 30th that authorizes the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 7.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on HCA shares. Oppenheimer reaffirmed an “outperform” rating and set a $315.00 price target on shares of HCA Healthcare in a research note on Wednesday, January 17th. Barclays started coverage on HCA Healthcare in a research report on Wednesday, March 6th. They set an “overweight” rating and a $356.00 price objective for the company. Truist Financial lifted their price objective on HCA Healthcare from $320.00 to $345.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Cantor Fitzgerald reiterated an “overweight” rating and set a $335.00 price objective on shares of HCA Healthcare in a research report on Wednesday, April 10th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on HCA Healthcare from $330.00 to $359.00 and gave the stock a “buy” rating in a research report on Friday, April 12th. Four analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $310.88.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.